NovApproach launches OneLIF interbody fusion device at NASS 2023

8291
OneLIF

NovApproach Spine recently announced the full market launch of its patented OneLIF interbody spinal fusion system, which supports “a multitude of surgical approaches”, during the 2023 North American Spine Society (NASS) annual meeting (18–21 October, Los Angeles, USA).

Spine surgeons face a myriad of complex and variable issues daily—often in a very challenging environment,” said NovApproach CEO Raymond Cloutier. “Our OneLIF cage was ‘born’ out of a request to provide a more versatile, less complex implant. It has been a joy to work with some of the most respected spine surgeons in the world to deliver the groundbreaking OneLIF device and SupineATP approach.”

OneLIF offers surgeons a single cage that supports three distinct approaches to the patient’s lumbar spine: anterior lumbar interbody fusion (ALIF), the LateralATP approach, and the SupineATP approach.

According to a NovApproach press release, this versatility enables surgeons to optimise their approach, while the OneLIF cage’s six fixation screw options and two inserter positions offer “unprecedented flexibility” to address varying patient pathologies. Since its limited launch in early 2022, surgeons have shared “excellent clinical feedback” on the device, the release adds.

“No other device supports this kind of intraoperative decision-making,” said Payam Moazzaz (Tri-City Medical Center, Oceanside, USA). “I can place the interbody through the direct anterior route or the ATP [anterior-to-psoas] oblique route and still maintain four-screw fixation along with safety features to prevent screw back-out.”

“I find access to certain levels of the spine can be challenging, based on the patient’s anatomy. The OneLIF cage’s multi-hole design addresses that,” added Erich Richter (Covenant Health, Saginaw, USA). “Additionally, the SupineATP approach allows my access surgeon to expose multiple levels of the spine without needing to reposition the patient.”

“OneLIF allows surgeons to attain the biomechanical advantages offered by an ALIF while minimising retraction to critical soft tissue structures and vasculature,” stated Sunil Jeswani (Spine and Brain Institute of San Diego, USA).


LEAVE A REPLY

Please enter your comment!
Please enter your name here